U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
UBLITUXIMAB
U59UGK3IPC
Other
General
Names
18
Classification
7
Identifiers
10
Subunits
4
Related Substances
1
UBLITUXIMAB
U59UGK3IPC
Other
General
Approval Year
Unknown
86,413
Names
18
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
UBLITUXIMAB
Official Name
English
R603
Code
English
TG-1101
Code
English
LFB-R 603
Code
English
EMAB6
Code
English
Showing 1 to 5 of 18 entries
Previous
1
2
3
4
Next
Classification
7
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of chronic lymphocytic leukemia
FDA ORPHAN DRUG
296609
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated
ORPHAN DRUG
Designated
Treatment of chronic lymphocytic leukemia
FDA ORPHAN DRUG
554216
Designated
ORPHAN DRUG
Designated
Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorder
FDA ORPHAN DRUG
533116
Designated
ORPHAN DRUG
Designated
Treatment of diffuse large B-cell lymphoma
FDA ORPHAN DRUG
552216
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Identifiers
10
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DRUG BANK
DB11850
PRIMARY
FDA UNII
U59UGK3IPC
PRIMARY
INN
9334
PRIMARY
WIKIPEDIA
Ublituximab
PRIMARY
CAS
1174014-05-1
PRIMARY
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
U59UGK3IPC
UBLITUXIMAB